Subscribe
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
SABCS 2023 - HER2+ MBC
ASCO 2023 - Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quizzes
Press Releases
AVBCC
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma
Issues
2014
August 2014, Vol 5, No 6
August 2014, Vol 5, No 6
Ramucirumab Improves Survival in Patients with Lung Cancer
By
Dana Butler
Lung Cancer
,
Personalized Medicine
,
Solid Tumors
August 2014, Vol 5, No 6
Chicago, IL—When added to chemotherapy (ie, docetaxel), the new monoclonal antibody ramucirumab improved overall survival (OS) compared with chemotherapy alone in patients with stage IV non–small-cell lung cancer (NSCLC), according to phase 3 trial results presented at the 2014 American Society of Clinical Oncology meeting.
Read Article
Necitumumab Extends Survival of Patients with Squamous Lung Cancer
By
Wayne Kuznar
Lung Cancer
,
Personalized Medicine
,
Solid Tumors
August 2014, Vol 5, No 6
Chicago, IL— Necitumumab, a human immunoglobulin G1 anti-EGFR monoclonal antibody, added to standard chemotherapy significantly improved survival compared with chemotherapy alone as first-line treatment of patients with stage IV non–small-cell lung cancer (NSCLC) of squamous histology.
Read Article
Association Between Indoor Tanning and Melanoma Confirmed in New Meta-Analysis
By
Rosemary Frei, MSc
Melanoma
,
Personalized Medicine
,
Solid Tumors
August 2014, Vol 5, No 6
Toronto, Ontario—Going to more than 10 indoor tanning sessions over a person’s lifetime is associated with a 34% increased risk of developing melanoma, according to a new meta-analysis presented at the 2014 Canadian Dermatology Association annual meeting.
Read Article
End Points in Oncology Clinical Trials: Revisiting Overall Survival
By
Ryan Saadi, MD, MPH
Clinical Trials
August 2014, Vol 5, No 6
When a promising investigational cancer drug enters a development area of great medical need, there is high pressure on the manufacturer from patients and from physicians to quickly secure patient access to this drug.
Read Article
QOPI Measures Identify Areas for Quality Improvement in Oncology Practice
By
Wayne Kuznar
Oncology Practice
August 2014, Vol 5, No 6
Los Angeles, CA—Value is the preeminent goal in cancer care, because it unites all of the interests of the stakeholders, including patients, said Douglas W. Blayney, MD, Medical Director, Stanford Cancer Institute, CA, at the Fourth Annual Conference of the Association for Value-Based Cancer Care.
Read Article
Big Data and CancerLinQ Can Help to Optimize Patient Outcomes in Oncology
By
Wayne Kuznar
August 2014, Vol 5, No 6
Los Angeles, CA—CancerLinQ is focused on improving quality of cancer care and enhancing outcomes by providing patients and providers real-time access to big data in a rapid electronic system, said George W. Sledge, Jr, MD, Chief, Division of Oncology, Stanford University Medical Center, CA.
Read Article
Using IBM Watson Electronic System to Guide Patient Management in Oncology
By
Wayne Kuznar
Oncology Practice
August 2014, Vol 5, No 6
Los Angeles, CA—IBM Watson computer is changing the face of oncology practice through its massive parallel computing system, utilizing natural language processing and cognitive machine computing. Unlike HAL 9000 from the movie 2001: A Space Odyssey, the IBM Watson system does not interpret the results but rather builds on information it receives from previous operations and offers possible solutions to new queries, said Mark G. Kris, MD, William and Joy Ruane Chair, Thoracic Oncology, Memorial Sloan Kettering Cancer Center, New York, at the Fourth Annual Conference of the Association for Value-Based Cancer Care.
Read Article
Oncology Pipeline Bustling, But Value Concerns Lead to Increased Payer Scrutiny
By
Wayne Kuznar
August 2014, Vol 5, No 6
Los Angeles, CA—Targeted therapies have dramatically increased their share of global oncology sales over the past decade. But concerns over value have led to more payer scrutiny of targeted therapies and other oncology drugs, suggested Doug Long, Vice President, Industry Relations, IMS Health, at the Fourth Annual Conference of the Association for Value-Based Cancer Care.
Read Article
Upfront Docetaxel Markedly Improves Survival
By
Wayne Kuznar
Personalized Medicine
,
Prostate Cancer
,
Solid Tumors
August 2014, Vol 5, No 6
Chicago, IL—The upfront addition of docetaxel to androgen deprivation therapy (ADT) adds more than 1 year to overall survival (OS) compared with ADT alone in men with newly diagnosed hormone-sensitive prostate cancer, according to findings from a phase 3 study presented at the 2014 American Society of Clinical Oncology meeting.
Read Article
Adjuvant Exemestane More Effective than Tamoxifen in Early-Stage Breast Cancer
By
Wayne Kuznar
Breast Cancer
,
Personalized Medicine
,
Solid Tumors
August 2014, Vol 5, No 6
Chicago, IL—Adjuvant exemestane is more effective at preventing breast cancer recurrences than tamoxifen when given with ovarian function suppression (OFS) in young women with hormone receptor–positive early breast cancer, reported Olivia Pagani, MD, Clinical Director, Breast Unit, Oncology Institute of Southern Switzerland, Bellinzona, at the 2014 American Society of Clinical Oncology meeting.
Read Article
Page 1 of 4
1
2
3
4
View the Latest Issue of VBCC
Read Issue
Top Trending Articles
1.
Navigating the Complex Landscape of Oral Cancer Medication
2.
Luspatercept Yields Improved Transfusion Independence Compared With Epoetin Alfa in Patients With Lower-Risk MDS
Phoebe Starr
3.
New NCCN Guidelines for CLL/SLL Include Second-Generation BTK Inhibitors
Wayne Kuznar
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
SABCS 2023 - HER2+ MBC
ASCO 2023 - Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quizzes
Press Releases
AVBCC
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma